|
|
Volumn 12, Issue 17, 2002, Pages 2377-2380
|
|
Fused azaindole derivatives: Molecular design, synthesis and in vitro pharmacology leading to the preferential dopamine D3 receptor agonist FAUC 725
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZAINDOLE;
DIPROPYLAMINE;
DOPAMINE 1 RECEPTOR;
DOPAMINE 2 RECEPTOR;
DOPAMINE 3 RECEPTOR;
DOPAMINE 3 RECEPTOR STIMULATING AGENT;
DOPAMINE 4 RECEPTOR;
HETEROCYCLIC COMPOUND;
INDOLE DERIVATIVE;
PRAMIPEXOLE;
PRECLAMOL;
UNCLASSIFIED DRUG;
DOPAMINE RECEPTOR STIMULATING AGENT;
DRD3 PROTEIN, HUMAN;
FAUC 725;
FUSED HETEROCYCLIC RINGS;
ARTICLE;
BINDING AFFINITY;
CONFORMATION;
CONTROLLED STUDY;
DRUG DESIGN;
DRUG SELECTIVITY;
DRUG SYNTHESIS;
ELECTRICITY;
IN VITRO STUDY;
MITOGENESIS;
NONHUMAN;
RECEPTOR BINDING;
CHEMICAL STRUCTURE;
DRUG POTENTIATION;
HUMAN;
PROTEIN BINDING;
SENSITIVITY AND SPECIFICITY;
STRUCTURE ACTIVITY RELATION;
SYNTHESIS;
AZA COMPOUNDS;
DOPAMINE AGONISTS;
DRUG DESIGN;
ELECTROSTATICS;
HETEROCYCLIC COMPOUNDS, 3-RING;
HUMANS;
INDOLES;
MODELS, MOLECULAR;
PROTEIN BINDING;
RECEPTORS, DOPAMINE D2;
RECEPTORS, DOPAMINE D3;
SENSITIVITY AND SPECIFICITY;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
|
EID: 0037009194
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0960-894X(02)00390-6 Document Type: Article |
|
Times cited : (49)
|
|
References (25)
|
